New Technology by Cambridge University Ensures Sustained Release of Injections of Diabetes,Cancer and AIDS for up to Six months

A new technology which delivers sustained release of therapeutics for up to six months could be used in conditions which require routine injections, including diabetes, certain forms of cancer and potentially HIV/AIDS.

Researchers from the University of Cambridge have developed injectable, reformable and spreadable hydrogels which can be loaded with proteins or other therapeutics. The hydrogels contain up to 99.7% water by weight, with the remainder primarily made up of cellulose polymers held together with cucurbiturils – barrel-shaped molecules which act as miniature ‘handcuffs’.

read here

About these ads

About Rashid Faridi

I am Rashid Aziz Faridi ,Writer, Teacher and a Voracious Reader.
This entry was posted in News. Bookmark the permalink.

2 Responses to New Technology by Cambridge University Ensures Sustained Release of Injections of Diabetes,Cancer and AIDS for up to Six months

  1. lenrosen4 says:

    Thank you for alerting me to this new biotechnology. I will feature it in this week’s headlines and credit you as my blogging source.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Connecting to %s